Seeking Alpha

Watson Pharmaceuticals (WPI) sells its Rugby OTC pharmaceutical products and trademarks to The...

Watson Pharmaceuticals (WPI) sells its Rugby OTC pharmaceutical products and trademarks to The Harvard Drug Group for approximately $117M. The Rugy OTC portfolio includes more than 250 cough and cold, allergy, pain relief, nausea relief, nicotine gum, vitamin and nutritional supplement products sold through various healthcare outlets across the United States. The FDA had pre-cleared the deal back on October 19.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector